1. "Fact sheet: Twelve Major Cancers." What You Need to Know About Cancer.  New York: W.H.
Freeman and Company, 1997. 27, 32, 95-6.

2. Coughlin, Steven S., James D. Neaton, Bryan Randall, Anjana Sengupta.  "Predictors of Mortality from Kidney Cancer in 332,547 Men Screened for the Multiple Risk Factor Intervention Trial." Cancer, Vol. 79, No. 11,  June 1, 1997.  2171-2177.

3. Chow, Wong-Ho, Susan S. Devesa, Joan L. Warren, Joseph F. Fraumeni.  "Rising Incidence of Renal Cell Cancer in the United States." The Journal of the American Medical Association, Vol. 281, No.17, May 5, 1999.  1628-1631.

4. Litwin, Mark S., Jennifer T. Fine, Frederick Dorey, Robert A. Filgin and Arie S. Belldegrun.  "Health Related Quality of Life Outcomes in Patients Treated for Metastatic Kidney Cancer: A Pilot Study." The Journal of Urology, Vol. 157, No. 5, May 1997. 1618-1612.

5. Yagoda, Alan and Carl Olsson. "Neoplasms of the Kidney, Bladder and Prostate." Medical Oncology, second edition.  New York: McGraw-Hill, Inc, 1993. 893-900.

6. Cangiano, Thomas, Joseph Liao, John Naitoh, Frederick Dorey, Robert Figlin and Arie Belldegrun. "Sarcomatoid Renal Cell Carcinoma: Biologic Behavior, Prognosis, and Response to Combined Surgical Resection and Immunotherapy."  Journal of Clinical Oncology, Vol. 17, No2,  Feb. 1999.  523-528.

7. Muscat, Joshua E., Dietrich Hoffmann, Ernst L. Wynder.  "The Epidemiology of Renal Cell Carcinoma." Cancer, Vol. 75, No. 10, May 15, 1995.  2552-2557.

8. Richie, Jerome, Philip W. Kantoff, Charles L. Shapiro. "Renal Cell Carcinoma." Cancer Medicine, Vol 2.  Baltimore: Williams and Wilkins, 1997. 2085-2096.

9. Marshall, Fray F., Andrew K. Stewart, Herman R. Menck.  "The National Cancer Data Base Report on Kidney Cancers." Cancer, Vol. 80, No.11, December 1, 1997. 2167-2174.

10. Tannock, Ian F. Ed., Richard P. Hill. The Basic Science of Oncology. New York: Pergamon Press. 1987. 2,3,37,91-3.

11. Weinberg, Robert A. ìHow Cancer Arises.î  What You Need to Know About Cancer.  New York: W.H. Freeman and Company, 1997. 3-14.

12. Kuby, Janis.  Immunology, third edition.  New York: W.H. Freeman and Company, 1997. 573-594

13. http://www.brown.edu/Courses/Bio_160/projects/cancer/imevstca.html

14. Ruddon, Raymond W.  Cancer Biology, second edition.  New York: Oxford University Press, 1987. 485-494.

15. Lisztwan, Joanna, Georges Imbert, Christiane Wirbelauer, Matthias Gstaiger, Wilhem Krek.  "The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity."  Genes & Development, Vol. 13, No. 14, July 15, 1999. 1822-1833

16. Thrash-Bingham, Catherine A, Kenneth D. Tartof.  "aHIF: a Natural Antisense Transcript Overexpressed in Human Renal Cancer and During Hypoxia." Journal of the National Cancer Institute, Vol. 91, No.2, January 20, 1999. 143-151.

17. Kaelin, William G. Jr., Eamonn R.Maher. "The VHL tumor-suppressor gene paradigm." Trends in Genetics, Vol. 14, No 10, October 1998. 423-426.

18. Schmidt, Laura, et al.  "Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas." Nature Genetics, Vol. 16, May 1997.  68-73.

19. Menke, A.L., A.J. van der Eb, A.G. Jochemsen. "The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?"  International Review of Cytology, Vol. 18, 1998. 151-212.

20. Colvin, Robert B. and G. Richard Dickersin. "Pathology of Renal Tumors."  Genitourinary cancer. Philadelphia: W.B. Saunders Company, 1978. 84-106.